Human epidermal growth factor receptor 2 (HER2; ERBB2) is tyrosine kinase receptor and the mutation or amplification of which have been linked with human cancers, with lung cancer and breast cancer the most common (Connell & Doherty, 2017). This evidence concerns the gene ERBB2 and breast carcinoma.